Viewing Study NCT06517212

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2026-02-17 @ 9:53 PM
Study NCT ID: NCT06517212
Status: RECRUITING
Last Update Posted: 2024-11-27
First Post: 2024-07-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Tirzepatide Weight Loss for MRD+ Early Breast Cancer
Sponsor: Baylor Research Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Breast Neoplasms View
None Breast Cancers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TRIM View
None TRIM EBC View
None TRIM-EBC View
None tirzepatide View
None MRD View
None ctDNA View